Advertisement
Canada markets close in 5 hours 31 minutes

  • S&P/TSX

    22,390.22
    +14.39 (+0.06%)
     

  • S&P 500

    5,220.75
    +6.67 (+0.13%)
     

  • DOW

    39,510.59
    +122.83 (+0.31%)
     

  • CAD/USD

    0.7314
    +0.0003 (+0.04%)
     

  • CRUDE OIL

    79.53
    +0.27 (+0.34%)
     

  • Bitcoin CAD

    85,311.44
    +1,628.84 (+1.95%)
     

  • CMC Crypto 200

    1,295.73
    -62.28 (-4.59%)
     

  • GOLD FUTURES

    2,374.70
    +34.40 (+1.47%)
     

  • RUSSELL 2000

    2,069.47
    -4.16 (-0.20%)
     

  • 10-Yr Bond

    4.4870
    +0.0380 (+0.85%)
     

  • NASDAQ

    16,337.20
    -9.06 (-0.06%)
     

  • VOLATILITY

    12.90
    +0.21 (+1.65%)
     

  • FTSE

    8,437.85
    +56.50 (+0.67%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6792
    +0.0014 (+0.21%)
     
MARKETS LIVE BLOG:

STOCKS RISE AS DOW EYES GAIN FOR 8TH STRAIGHT SESSION

U.S. consumer sentiment falls in May as inflation, interest rate worries take hold

Top-Rated Ligand Pharmaceuticals Nearing A Buy Point

Investor's Business Daily Video
Updated

Ligand Pharmaceuticals, which has a highest-possible IBD Composite Rating of 99, is getting close to a buy point. Industry group peers Amgen and Alexion Pharmaceuticals have also formed bases. Should these biotechs be added to your stock watch list?